Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Medicinal Chemistry

Slow and steady action makes brain cancer drug candidate more selective

Researchers designed a molecule that kills brain cancer cells while giving healthy cells time to repair their DNA

by Brianna Barbu
June 1, 2024

Article:

This article has been sent to the following recipient: